Two cells are better than one: Optimizing stem cell survival by co-grafting "helper" cells that offer regulated trophic support

Experimental Neurology

Volumn 247, Issue , 2013, Pages 751-754

  Smith, Gaynor A ^a   Snyder, Evan Y ^b  

^a MCLEAN HOSPITAL   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; CELL DEGENERATION; CELL REGENERATION; CELL SURVIVAL; CELL VIABILITY; CEREBROVASCULAR ACCIDENT; DRUG EFFECT; DRUG EFFICACY; DRUG USE; ENDOPLASMIC RETICULUM STRESS; GENETIC ENGINEERING; HELPER CELL; HUMAN; IMMUNOMODULATION; NERVE CELL NETWORK; NERVE DEGENERATION; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; NOTE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN; DOXYCYCLINE; FIBROBLAST GROWTH FACTORS; HUMANS; MALE; NEURAL STEM CELLS;

EID: 84881376464     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.07.003     Document Type: Note

References (66)

1. Alberch J., Perez-Navarro E., Canals J.M. Neurotrophic factors in Huntington's disease. Prog. Brain Res. 2004, 146:195-229.
2. Ay I., Sugimori H., Finklestein S.P. Intravenous basic fibroblast growth factor (bFGF) decreases DNA fragmentation and prevents downregulation of Bcl-2 expression in the ischemic brain following middle cerebral artery occlusion in rats. Brain Res. Mol. Brain Res. 2001, 87:71-80.
3. Beck M., Flachenecker P., Magnus T., Giess R., Reiners K., Toyka K.V., Naumann M. Autonomic dysfunction in ALS: a preliminary study on the effects of intrathecal BDNF. Amyotrophic Lateral Scler. Other Mot. Neuron Disord. 2005, 6:100-103.
4. Bhang S.H., Lee Y.E., Cho S.W., Shim J.W., Lee S.H., Choi C.Y., Chang J.W., Kim B.S. Basic fibroblast growth factor promotes bone marrow stromal cell transplantation-mediated neural regeneration in traumatic brain injury. Biochem. Biophys. Res. Commun. 2007, 359:40-45.
5. Cali T., Ottolini D., Brini M. Calcium and endoplasmic reticulum-mitochondria tethering in neurodegeneration. DNA Cell Biol. 2013, 32:140-146.
6. Chen R., Yu B.H., Hu L., Yan Z., Wang W.D., Liu M. Changes of HSP70, bFGF and TGF-beta1 expression in rat brain after concussion. Fayixue Zazhi 2009, 25:249-253.
7. Chiang Y.H., Lin S.Z., Zhou F.C. Bridging nigrostriatal pathway with fibroblast growth factor-primed peripheral nerves and fetal ventral mesencephalon transplant recuperates from deficits in parkinsonian rats. Cell Transplant. 2006, 15:475-482.
8. Clough R.L., Stefanis L. A novel pathway for transcriptional regulation of alpha-synuclein. FASEB J. 2007, 21:596-607.
9. Cuevas P., Carceller F., Gimenez-Gallego G. Fibroblast growth factor and cerebral ischaemia. Neurol. Res. 1994, 16:181-183.
10. Deshpande D.M., Kim Y.S., Martinez T., Carmen J., Dike S., Shats I., Rubin L.L., Drummond J., Krishnan C., Hoke A., Maragakis N., Shefner J., Rothstein J.D., Kerr D.A. Recovery from paralysis in adult rats using embryonic stem cells. Ann. Neurol. 2006, 60:32-44.
11. Dietrich W.D., Alonso O., Busto R., Finklestein S.P. Posttreatment with intravenous basic fibroblast growth factor reduces histopathological damage following fluid-percussion brain injury in rats. J. Neurotrauma 1996, 13:309-316.
12. Epstein S.E., Fuchs S., Zhou Y.F., Baffour R., Kornowski R. Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovasc. Res. 2001, 49:532-542.
13. Evans J.R., Barker R.A. Neurotrophic factors as a therapeutic target for Parkinson's disease. Expert Opin. Ther. Targets 2008, 12:437-447.
14. Fontan A., Rojo A., Sanchez Pernaute R., Hernandez I., Lopez I., Castilla C., Sanchez Albisua J., Perez Higueras A., Al-Rashid I., Rabano A., Gonzalo I., Angeles Mena M., Cools A., Eshuis S., Maguire P., Pruim J., Leenders K., Garcia De Yebenes J. Effects of fibroblast growth factor and glial-derived neurotrophic factor on akinesia, F-DOPA uptake and dopamine cells in parkinsonian primates. Parkinsonism Relat. Disord. 2002, 8:311-323.
15. Frim D.M., Uhler T.A., Short M.P., Ezzedine Z.D., Klagsbrun M., Breakefield X.O., Isacson O. Effects of biologically delivered NGF, BDNF and bFGF on striatal excitotoxic lesions. Neuroreport 1993, 4:367-370.
16. Gaillard A., Jaber M. Rewiring the brain with cell transplantation in Parkinson's disease. Trends Neurosci. 2011, 34:124-133.
17. Galvin K.A., Jones D.G. Adult human neural stem cells for autologous cell replacement therapies for neurodegenerative disorders. NeuroRehabilitation 2006, 21:255-265.
18. Gogvadze V., Robertson J.D., Zhivotovsky B., Orrenius S. Cytochrome c release occurs via Ca2+-dependent and Ca2+-independent mechanisms that are regulated by Bax. J. Biol. Chem. 2001, 276:19066-19071.
19. Hsuan S.L., Klintworth H.M., Xia Z. Basic fibroblast growth factor protects against rotenone-induced dopaminergic cell death through activation of extracellular signal-regulated kinases 1/2 and phosphatidylinositol-3 kinase pathways. J. Neurosci. 2006, 26:4481-4491.
20. Kawamata T., Alexis N.E., Dietrich W.D., Finklestein S.P. Intracisternal basic fibroblast growth factor (bFGF) enhances behavioral recovery following focal cerebral infarction in the rat. J. Cereb. Blood Flow Metab. 1996, 16:542-547.
21. Kawamata T., Dietrich W.D., Schallert T., Gotts J.E., Cocke R.R., Benowitz L.I., Finklestein S.P. Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:8179-8184.
22. Kitchens D.L., Snyder E.Y., Gottlieb D.I. FGF and EGF are mitogens for immortalized neural progenitors. J. Neurobiol. 1994, 25:797-807.
23. Koh S.H., Baik W., Noh M.Y., Cho G.W., Kim H.Y., Kim K.S., Kim S.H. The functional deficiency of bone marrow mesenchymal stromal cells in ALS patients is proportional to disease progression rate. Exp. Neurol. 2012, 233:472-480.
24. Lane E.L., Smith G.A. Understanding graft-induced dyskinesia. Regener. Med. 2010, 5:787-797.
25. Lau H.T., Yu M., Fontana A., Stoeckert C.J. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 1996, 273:109-112.
26. Lavik E., Teng Y.D., Snyder E., Langer R. Seeding neural stem cells on scaffolds of PGA, PLA, and their copolymers. Methods Mol. Biol. 2002, 198:89-97.
27. Lee T.T., Green B.A., Dietrich W.D., Yezierski R.P. Neuroprotective effects of basic fibroblast growth factor following spinal cord contusion injury in the rat. J. Neurotrauma 1999, 16:347-356.
28. Liang Y., Agren L., Lyczek A., Walczak P., Bulte J.W. Neural progenitor cell survival in mouse brain can be improved by co-transplantation of helper cells expressing bFGF under doxycycline control. Exp. Neurol. 2013, 247C:73-79.
29. Liang Y., Walczak P., Bulte J.W. The survival of engrafted neural stem cells within hyaluronic acid hydrogels. Biomaterials 2013, 34:5521-5529.
30. Lindvall O., Kokaia Z. Stem cells in human neurodegenerative disorders-time for clinical translation?. J. Clin. Invest. 2010, 120:29-40.
31. Liu L., Lu B., Tu C.Q., Chi L.T., Wang G.L., Pei F.X. Effect of basic fibroblast growth factor on the expression of glial fibrillary acidic protein after tractive spinal cord injury in rats. Chin. J. Traumatol. 2005, 8:117-120.
32. Lu P., Jones L.L., Tuszynski M.H. BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Exp. Neurol. 2005, 191:344-360.
33. Lundqvist J., El Andaloussi-Lilja J., Svensson C., Gustafsson Dorfh H., Forsby A. Optimisation of culture conditions for differentiation of C17.2 neural stem cells to be used for in vitro toxicity tests. Toxicol. In Vitro 2013, 27:1565-1569.
34. Lynch W.P., Sharpe A.H., Snyder E.Y. Neural stem cells as engraftable packaging lines can mediate gene delivery to microglia: evidence from studying retroviral env-related neurodegeneration. J. Virol. 1999, 73:6841-6851.
35. Marconi S., Bonaconsa M., Scambi I., Squintani G.M., Rui W., Turano E., Ungaro D., D'Agostino S., Barbieri F., Angiari S., Farinazzo A., Constantin G., Del Carro U., Bonetti B., Mariotti R. Systemic treatment with adipose-derived mesenchymal stem cells ameliorates clinical and pathological features in the amyotrophic lateral sclerosis murine model. Neuroscience 2013, 248:333-343.
36. Moyse E., Segura S., Liard O., Mahaut S., Mechawar N. Microenvironmental determinants of adult neural stem cell proliferation and lineage commitment in the healthy and injured central nervous system. Curr. Stem Cell Res. Ther. 2008, 3:163-184.
37. Nakagawa T., Schwartz J.P. Gene expression profiles of reactive astrocytes in dopamine-depleted striatum. Brain Pathol. 2004, 14:275-280.
38. Ourednik J., Ourednik V., Lynch W.P., Schachner M., Snyder E.Y. Neural stem cells display an inherent mechanism for rescuing dysfunctional neurons. Nat. Biotechnol. 2002, 20:1103-1110.
39. Ourednik V., Ourednik J., Xu Y., Zhang Y., Lynch W.P., Snyder E.Y., Schachner M. Cross-talk between stem cells and the dysfunctional brain is facilitated by manipulating the niche: evidence from an adhesion molecule. Stem Cells 2009, 27:2846-2856.
40. Paciaroni M., Bogousslavsky J. Trafermin for stroke recovery: is it time for another randomized clinical trial?. Expert Opin. Biol. Ther. 2011, 11:1533-1541.
41. Park K.I., Teng Y.D., Snyder E.Y. The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat. Biotechnol. 2002, 20:1111-1117.
42. Park K.I., Hack M.A., Ourednik J., Yandava B., Flax J.D., Stieg P.E., Gullans S., Jensen F.E., Sidman R.L., Ourednik V., Snyder E.Y. Acute injury directs the migration, proliferation, and differentiation of solid organ stem cells: evidence from the effect of hypoxia-ischemia in the CNS on clonal "reporter" neural stem cells. Exp. Neurol. 2006, 199:156-178.
43. Park K.I., Himes B.T., Stieg P.E., Tessler A., Fischer I., Snyder E.Y. Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: evidence from engraftment of Neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury. Exp. Neurol. 2006, 199:179-190.
44. Paschen W., Mengesdorf T. Endoplasmic reticulum stress response and neurodegeneration. Cell Calcium 2005, 38:409-415.
45. Peluso J.J. Basic fibroblast growth factor (bFGF) regulation of the plasma membrane calcium ATPase (PMCA) as part of an anti-apoptotic mechanism of action. Biochem. Pharmacol. 2003, 66:1363-1369.
46. Pluchino S., Cossetti C. How stem cells speak with host immune cells in inflammatory brain diseases 2013, Glia.
47. Redmond D.E., Bjugstad K.B., Teng Y.D., Ourednik V., Ourednik J., Wakeman D.R., Parsons X.H., Gonzalez R., Blanchard B.C., Kim S.U., Gu Z., Lipton S.A., Markakis E.A., Roth R.H., Elsworth J.D., Sladek J.R., Sidman R.L., Snyder E.Y. Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:12175-12180.
48. Ruiz C., Casarejos M.J., Gomez A., Solano R., De Yebenes J.G., Mena M.A. Protection by glia-conditioned medium in a cell model of Huntington disease. PLoS Curr. 2012, 4. (e4fbca54a2028b).
49. Schuettauf F., Vorwerk C., Naskar R., Orlin A., Quinto K., Zurakowski D., Dejneka N.S., Klein R.L., Meyer E.M., Bennett J. Adeno-associated viruses containing bFGF or BDNF are neuroprotective against excitotoxicity. Curr. Eye Res. 2004, 29:379-386.
50. Shen H., Tang Y., Wu Y., Chen Y., Cheng Z. Influences of olfactory ensheathing cells transplantation on axonal regeneration in spinal cord of adult rats. Chin. J. Traumatol. 2002, 5:136-141.
51. Shim J.W., Koh H.C., Chang M.Y., Roh E., Choi C.Y., Oh Y.J., Son H., Lee Y.S., Studer L., Lee S.H. Enhanced in vitro midbrain dopamine neuron differentiation, dopaminergic function, neurite outgrowth, and 1-methyl-4-phenylpyridium resistance in mouse embryonic stem cells overexpressing Bcl-XL. J. Neurosci. 2004, 24:843-852.
52. Smith G.M., Onifer S.M. Construction of pathways to promote axon growth within the adult central nervous system. Brain Res. Bull. 2011, 84:300-305.
53. Smith G.A., Breger L.S., Lane E.L., Dunnett S.B. Pharmacological modulation of amphetamine-induced dyskinesia in transplanted hemi-parkinsonian rats. Neuropharmacology 2012, 63:818-828.
54. Snyder E.Y., Teng Y.D. Stem cells and spinal cord repair. N. Engl. J. Med. 2012, 366:1940-1942.
55. Sun D., Bullock M.R., Mcginn M.J., Zhou Z., Altememi N., Hagood S., Hamm R., Colello R.J. Basic fibroblast growth factor-enhanced neurogenesis contributes to cognitive recovery in rats following traumatic brain injury. Exp. Neurol. 2009, 216:56-65.
56. Suzuki M., McHugh J., Tork C., Shelley B., Klein S.M., Aebischer P., Svendsen C.N. GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS One. 2007, 2(8):e689.
57. Teng Y.D., Lavik E.B., Qu X., Park K.I., Ourednik J., Zurakowski D., Langer R., Snyder E.Y. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:3024-3029.
58. Teng Y.D., Benn S.C., Kalkanis S.N., Shefner J.M., Onario R.C., Cheng B., Lachyankar M.B., Marconi M., Li J., Yu D., Han I., Maragakis N.J., Llado J., Erkmen K., Redmond D.E., Sidman R.L., Przedborski S., Rothstein J.D., Brown R.H., Snyder E.Y. Multimodal actions of neural stem cells in a mouse model of ALS: a meta-analysis. Sci. Transl. Med. 2012, 4:165ra164.
59. Tooyama I. Fibroblast growth factors (FGFs) in neurodegenerative disorders. Rinsho Shinkeigaku 1993, 33:1270-1274.
60. Tooyama I., Kremer H.P., Hayden M.R., Kimura H., Mcgeer E.G., Mcgeer P.L. Acidic and basic fibroblast growth factor-like immunoreactivity in the striatum and midbrain in Huntington's disease. Brain Res. 1993, 610:1-7.
61. Wang Z.L., Cheng S.M., Ma M.M., Ma Y.P., Yang J.P., Xu G.L., Liu X.F. Intranasally delivered bFGF enhances neurogenesis in adult rats following cerebral ischemia. Neurosci. Lett. 2008, 446:30-35.
62. Wang Q., Ishikawa T., Michiue T., Zhu B.L., Guan D.W., Maeda H. Evaluation of human brain damage in fatalities due to extreme environmental temperature by quantification of basic fibroblast growth factor (bFGF), glial fibrillary acidic protein (GFAP), S100beta and single-stranded DNA (ssDNA) immunoreactivities. Forensic Sci. Int. 2012, 219:259-264.
63. Wong H.L., Wang M.X., Cheung P.T., Yao K.M., Chan B.P. A 3D collagen microsphere culture system for GDNF-secreting HEK293 cells with enhanced protein productivity. Biomaterials 2007, 28:5369-5380.
64. Wu C.Y., Whye D., Mason R.W., Wang W. Efficient differentiation of mouse embryonic stem cells into motor neurons. J. Vis. Exp. 2012, e3813.
65. Zhang H.Y., Wang Z.G., Wu F.Z., Kong X.X., Yang J., Lin B.B., Zhu S.P., Lin L., Gan C.S., Fu X.B., Li X.K., Xu H.Z., Xiao J. Regulation of autophagy and ubiquitinated protein accumulation by bFGF promotes functional recovery and neural protection in a rat model of spinal cord injury. Mol. Neurobiol. 2013, (in press).
66. Zhang H.Y., Zhang X., Wang Z.G., Shi H.X., Wu F.Z., Lin B.B., Xu X.L., Wang X.J., Fu X.B., Li Z.Y., Shen C.J., Li X.K., Xiao J. Exogenous basic fibroblast growth factor inhibits ER stress-induced apoptosis and improves recovery from spinal cord injury. CNS Neurosci. Ther. 2013, 19:20-29.